Medication Administration Outside Ordered Parameters and Use of Expired Insulin Pen
Summary
The facility failed to follow professional standards of nursing practice when medications with ordered hold parameters were administered without first obtaining the required blood sugar or blood pressure assessments, or were given despite values outside the ordered parameters. For Resident #45, who had diabetes, metformin was administered on multiple occasions when the blood sugar was below the ordered hold parameter of 120 mg/dl, including times when the blood sugar was 108, 103, 88, 116, 95, 103, and 93. The record also showed occasions when the evening blood sugar was not assessed before metformin was given, and there was no documentation explaining administration outside the ordered parameters. For Resident #47, who also had diabetes, Humalog was ordered before meals with instructions to hold if blood sugar was less than 120 mg/dl. The record showed Humalog was administered when the blood sugar was 116, 118, 118, 93, and 110, and one dose was documented as not given when the blood sugar was 120. The record also showed an evening dose was administered using a blood sugar result from earlier in the day rather than an assessment at the time of the dose, and there was no documentation explaining administration outside the ordered parameters or the withholding of the dose. For Resident #95, who had heart disease and hypertension, Cozaar was ordered with instructions to hold if systolic blood pressure was less than 120 mmHg. The medication was administered on multiple occasions when systolic blood pressure readings were below 120, including 115, 108, 115, 100, 100, 115, 117, 108, 98, 108, 114, 106, 109, and 115, and on two occasions the blood pressure was not assessed before administration. For Resident #53, who had hypotension, Midodrine was ordered three times daily with instructions to hold if systolic blood pressure was greater than 140. The record showed the medication was administered when the blood pressure was 136/61 and 125/52, and on several occasions the 2:00 PM dose was given without a current blood pressure assessment, using an earlier reading instead. The record also showed no documentation explaining administration outside the ordered parameters or the lack of assessment prior to administration. The facility also failed to follow manufacturer storage and use instructions for Resident #29's Lantus SoloStar insulin pen. A pen labeled for the resident remained in the medication cart beyond the manufacturer's recommended 28-day use period, and the MAR showed the resident received two doses from that pen after the expiration date. The facility policies reviewed stated that medications are to be stored according to manufacturer recommendations and that expired medications are to be identified and reported.
Penalty
Resources
Below are regulatory guidelines relevant to this citation:
Trusted data from CMS and state health departments
Every citation, penalty and Plan of Correction is sourced from public CMS records (latest release July 29, 2026) and official state health department websites — never guesswork.
In your survey window? See what surveyors are citing.
The Survey-Prep Report maps your facility's risk from 12 months of CMS and state citation data — what's being cited around you and what to check first. $129 one-time.